Injective Price Corrects 4.2% After Rally

Injective's (INJ) price has dropped by 4.2% over the last 24 hours, but this decline is largely seen as a correction after a significant rally.

The recent drop in INJ's price can be attributed to profit taking and market normalization following a strong catalyst-driven run.

Several positive listings and integrations with Kraken and Robinhood, as well as Pineapple Financial's large mortgage tokenization program on Injective, had contributed to the prior rally.

The 4.23% decline in INJ's price is best understood as a standard correction after a rapid multi-day rally, rather than a standalone bearish signal.